Polysorbate 80 (HX2)™ Is in Compliance With The Chinese Pharmacopoeia
[ Posted: 10/29/2022 Category: News ]

Polysorbate 80 (HX2)™ Is in Compliance With The Chinese Pharmacopoeia

We are pleased to inform you that we have submitted a Drug Master File to the CDE (Center for Drug Evaluation, National Medical Products Administration) for our Polysorbate 80 (HX2)™.

Polysorbate 80 (HX2)™, our ultrapure polysorbate 80, is now in compliance with the United States Pharmacopeia (USP), the European Pharmacopoeia (EP), the Japanese Pharmacopoeia (JP), and the Chinese Pharmacopoeia (ChP for injection).

Polysorbate 80 (HX2)™ can be used for the development of a wide range of pharmaceutical products intended for the Chinese market.

Back to All Articles

For further information, please refer to the following contact information.

New York Office

One North Broadway, Suite 912
White Plains, NY 10601
1(866) NOF-0001
(914) 681-9790
(914) 681-9791
info@nofamerica.com

San Francisco Office

Drug Delivery Products only

400 Concar Dr. 2nd Fl Unit 156
San Mateo, CA 94402
(650) 993-7375
(650) 993-7376

NOF AMERICA Nichiyu

(Boston Office)

1 Beacon St.,
Boston, MA 02108
(914) 704-7903
(914) 681-9791